AAAAAA

   
Results: 1-16 |
Results: 16
Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA
Authors: Colucci, M D'Aprile, AM Italia, A Gresele, P Morser, J Semeraro, N
Citation: M. Colucci et al., Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA, THROMB HAEM, 85(4), 2001, pp. 661-666
FXa-induced responses in vascular wall cells are PAR-mediated and inhibited by ZK-807834
Authors: McLean, K Schirm, S Johns, A Morser, J Light, DR
Citation: K. Mclean et al., FXa-induced responses in vascular wall cells are PAR-mediated and inhibited by ZK-807834, THROMB RES, 103(4), 2001, pp. 281-297
Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator
Authors: Schenk-Braat, EAM Morser, J Rijken, DC
Citation: Eam. Schenk-braat et al., Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator, EUR J BIOCH, 268(21), 2001, pp. 5562-5569
Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice
Authors: Wang, YX Martin-McNulty, B Freay, AD Sukovich, DA Halks-Miller, M Li, WW Vergona, R Sullivan, ME Morser, J Dole, WP Deng, GG
Citation: Yx. Wang et al., Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice, AM J PATH, 159(4), 2001, pp. 1455-1464
An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model
Authors: Nagashima, M Werner, M Wang, M Zhao, L Light, DR Pagila, R Morser, J Verhallen, P
Citation: M. Nagashima et al., An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model, THROMB RES, 98(4), 2000, pp. 333-342
Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex
Authors: Fuentes-Prior, P Iwanaga, Y Huber, R Pagila, R Rumennik, G Seto, M Morser, J Light, DR Bode, W
Citation: P. Fuentes-prior et al., Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex, NATURE, 404(6777), 2000, pp. 518-525
Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme
Authors: Yan, W Wu, FY Morser, J Wu, QY
Citation: W. Yan et al., Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme, P NAS US, 97(15), 2000, pp. 8525-8529
Elements of the primary structure of thrombomodulin required for efficientthrombin-activable fibrinolysis inhibitor activation
Authors: Wang, W Nagashima, M Schneider, M Morser, J Nesheim, M
Citation: W. Wang et al., Elements of the primary structure of thrombomodulin required for efficientthrombin-activable fibrinolysis inhibitor activation, J BIOL CHEM, 275(30), 2000, pp. 22942-22947
KIAP, a novel member of the inhibitor of apoptosis protein family
Authors: Lin, JH Deng, G Huang, QH Morser, J
Citation: Jh. Lin et al., KIAP, a novel member of the inhibitor of apoptosis protein family, BIOC BIOP R, 279(3), 2000, pp. 820-831
Probing the activation of protein C by the thrombin-thrombomodulin complexusing structural analysis, site-directed mutagenesis, and computer modeling
Authors: Knobe, KE Berntsdotter, A Shen, L Morser, J Dahlback, B Villoutreix, BO
Citation: Ke. Knobe et al., Probing the activation of protein C by the thrombin-thrombomodulin complexusing structural analysis, site-directed mutagenesis, and computer modeling, PROTEINS, 35(2), 1999, pp. 218-234
RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides
Authors: Hofmann, MA Drury, S Fu, CF Qu, W Taguchi, A Lu, Y Avila, C Kambham, N Bierhaus, A Nawroth, P Neurath, MF Slattery, T Beach, D McClary, J Nagashima, M Morser, J Stern, D Schmidt, AM
Citation: Ma. Hofmann et al., RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides, CELL, 97(7), 1999, pp. 889-901
The human and rat recombinant receptors for advanced glycation end products have a high degree of homology but different pharmacokinetic properties in rats
Authors: Renard, C Chappey, O Wautier, MP Nagashima, M Morser, J Scherrmann, JM Wautier, JL
Citation: C. Renard et al., The human and rat recombinant receptors for advanced glycation end products have a high degree of homology but different pharmacokinetic properties in rats, J PHARM EXP, 290(3), 1999, pp. 1458-1466
Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains
Authors: Hall, SW Nagashima, M Zhao, L Morser, J Leung, LLK
Citation: Sw. Hall et al., Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains, J BIOL CHEM, 274(36), 1999, pp. 25510-25516
Corin, a mosaic transmembrane serine protease encoded by a novel cDNA fromhuman heart
Authors: Yan, W Sheng, N Seto, M Morser, J Wu, QY
Citation: W. Yan et al., Corin, a mosaic transmembrane serine protease encoded by a novel cDNA fromhuman heart, J BIOL CHEM, 274(21), 1999, pp. 14926-14935
The interaction of thrombomodulin with Ca2+
Authors: Light, DR Glaser, CB Betts, M Blasko, E Campbell, E Clarke, JH McCaman, M McLean, K Nagashima, M Parkinson, JF Rumennik, G Young, T Morser, J
Citation: Dr. Light et al., The interaction of thrombomodulin with Ca2+, EUR J BIOCH, 262(2), 1999, pp. 522-533
Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms
Authors: Zhao, L Morser, J Bajzar, L Nesheim, M Nagashima, M
Citation: L. Zhao et al., Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms, THROMB HAEM, 80(6), 1998, pp. 949-955
Risultati: 1-16 |